NCT01250665View on ClinicalTrials.gov

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

UnknownOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Multiple SclerosisCognitive Impairment
Trial Locations (1)

9007

Cantonal Hospital of Saint Gallen, Sankt Gallen

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Cantonal Hospital of St. Gallen

OTHER